What we know — and don’t know — about Merck’s new Covid-19 pill – STAT Related: [Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19. Merck’s Covid-19 pill is great news but […]

The post What we know — and don’t know — about Merck’s new Covid-19 pill. appeared first on Links Medicus.